Fusobacterium nucleatum — symbiont, opportunist and oncobacterium (original) (raw)

• Hug, L. A. et al. A new view of the tree of life. Nat. Microbiol. 1, 16048 (2016).
  CAS PubMed Google Scholar
• Parks, D. H. et al. Recovery of nearly 8,000 metagenome-assembled genomes substantially expands the tree of life. Nat. Microbiol. 2, 1533–1542 (2017).
  CAS PubMed Google Scholar
• Zhao, J.-S., Manno, D. & Hawari, J. Psychrilyobacter atlanticus gen. nov., sp. nov., a marine member of the phylum Fusobacteria that produces H2 and degrades nitramine explosives under low temperature conditions. Int. J. Syst. Evol. Microbiol. 59, 491–497 (2009).
  CAS PubMed Google Scholar
• Kolenbrander, P. E., Palmer, R. J., Periasamy, S. & Jakubovics, N. S. Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Microbiol. 8, 471–480 (2010).
  CAS PubMed Google Scholar
• Lancy, P., Dirienzo, J. M., Appelbaum, B., Rosan, B. & Holt, S. C. Corncob formation between Fusobacterium nucleatum and Streptococcus sanguis. Infect. Immun. 40, 303–309 (1983).
  PubMed PubMed Central Google Scholar
• Guo, L., Shokeen, B., He, X., Shi, W. & Lux, R. Streptococcus mutans SpaP binds to RadD of Fusobacterium nucleatum ssp. polymorphum. Mol. Oral Microbiol. 32, 355–364 (2017).
  CAS PubMed PubMed Central Google Scholar
• Kaplan, C. W., Lux, R., Haake, S. K. & Shi, W. The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm. Mol. Microbiol. 71, 35–47 (2009).
  CAS PubMed Google Scholar
• Wu, T. et al. Cellular components mediating coadherence of Candida albicans and Fusobacterium nucleatum. J. Dent. Res. 94, 1432–1438 (2015).
  CAS PubMed PubMed Central Google Scholar
• Manson McGuire, A. et al. Evolution of invasion in a diverse set of Fusobacterium species. MBio 5, e01864 (2014). This publication is a comparative genomic analysis of sequenced Fusobacterium species focused on potential mechanisms of molecular pathogenesis.
  PubMed PubMed Central Google Scholar
• Zanzoni, A., Spinelli, L., Braham, S. & Brun, C. Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins. Microbiome 5, 89 (2017).
  PubMed PubMed Central Google Scholar
• Tan, K. H. et al. Porphyromonas gingivalis and Treponema denticola exhibit metabolic symbioses. PLOS Pathog. 10, e1003955 (2014).
  PubMed PubMed Central Google Scholar
• Sakanaka, A., Kuboniwa, M., Takeuchi, H., Hashino, E. & Amano, A. Arginine-ornithine antiporter ArcD controls arginine metabolism and interspecies biofilm development of Streptococcus gordonii. J. Biol. Chem. 290, 21185–21198 (2015).
  CAS PubMed PubMed Central Google Scholar
• Hendrickson, E. L. et al. Proteomics of Fusobacterium nucleatum within a model developing oral microbial community. Microbiologyopen 3, 729–751 (2014).
  CAS PubMed PubMed Central Google Scholar
• Mark Welch, J. L., Rossetti, B. J., Rieken, C. W., Dewhirst, F. E. & Borisy, G. G. Biogeography of a human oral microbiome at the micron scale. Proc. Natl Acad. Sci. USA 113, E791–E800 (2016). This publication is a technical re-exploration of the spatial organization of the microbiota in the oral cavity, revealing new layers of complexity.
  CAS PubMed PubMed Central Google Scholar
• Krisanaprakornkit, S. et al. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68, 2907–2915 (2000).
  CAS PubMed PubMed Central Google Scholar
• Ahn, S.-H. et al. Transcriptome profiling analysis of senescent gingival fibroblasts in response to Fusobacterium nucleatum infection. PLOS ONE 12, e0188755 (2017).
  PubMed PubMed Central Google Scholar
• Bhattacharyya, S. et al. FAD-I, a Fusobacterium nucleatum cell wall-associated diacylated lipoprotein that mediates human beta defensin 2 induction through Toll-like receptor-1/2 (TLR-1/2) and TLR-2/6. Infect. Immun. 84, 1446–1456 (2016).
  PubMed PubMed Central Google Scholar
• Gallimidi, A. B. et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget 6, 22613–22623 (2015).
  PubMed Central Google Scholar
• Park, S.-R. et al. Diverse Toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages. Infect. Immun. 82, 1914–1920 (2014).
  PubMed PubMed Central Google Scholar
• Taxman, D. J. et al. Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis. J. Biol. Chem. 287, 32791–32799 (2012).
  CAS PubMed PubMed Central Google Scholar
• Saito, A. et al. Porphyromonas gingivalis entry into gingival epithelial cells modulated by Fusobacterium nucleatum is dependent on lipid rafts. Microb. Pathog. 53, 234–242 (2012).
  CAS PubMed PubMed Central Google Scholar
• Metzger, Z. et al. Synergistic pathogenicity of Porphyromonas gingivalis and Fusobacterium nucleatum in the mouse subcutaneous chamber model. J. Endod. 35, 86–94 (2009).
  PubMed Google Scholar
• Swidsinski, A. et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60, 34–40 (2011).
  PubMed Google Scholar
• Han, X. Y. et al. Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. J. Neurosurg. 99, 693–700 (2003).
  PubMed Google Scholar
• Gregory, S. W., Boyce, T. G., Larson, A. N., Patel, R. & Jackson, M. A. Fusobacterium nucleatum osteomyelitis in 3 previously healthy children: a case series and review of the literature. J. Pediatr. Infect. Dis. Soc. 4, e155–e159 (2015).
  Google Scholar
• Truant, A. L., Menge, S., Milliorn, K., Lairscey, R. & Kelly, M. T. Fusobacterium nucleatum pericarditis. J. Clin. Microbiol. 17, 349–351 (1983).
  CAS PubMed PubMed Central Google Scholar
• Altshuler, G. & Hyde, S. Clinicopathologic considerations of fusobacteria chorioamnionitis. Acta Obstet. Gynecol. Scand. 67, 513–517 (1988).
  CAS PubMed Google Scholar
• Tjalsma, H., Boleij, A., Marchesi, J. R. & Dutilh, B. E. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 10, 575–582 (2012).
  CAS PubMed Google Scholar
• Strauss, J. et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 17, 1971–1978 (2011).
  PubMed Google Scholar
• Ikegami, A., Chung, P. & Han, Y. W. Complementation of the fadA mutation in Fusobacterium nucleatum demonstrates that the surface-exposed adhesin promotes cellular invasion and placental colonization. Infect. Immun. 77, 3075–3079 (2009).
  CAS PubMed PubMed Central Google Scholar
• Han, Y. W. et al. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect. Immun. 68, 3140–3146 (2000).
  CAS PubMed PubMed Central Google Scholar
• Kinder Haake, S. & Lindemann, R. A. Fusobacterium nucleatum T18 aggregates human mononuclear cells and inhibits their PHA-stimulated proliferation. J. Periodontol. 68, 39–44 (1997).
  CAS PubMed Google Scholar
• Gursoy, U. K., Könönen, E. & Uitto, V.-J. Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells. APMIS 116, 1063–1070 (2008).
  PubMed Google Scholar
• Weiss, E. I. et al. Attachment of Fusobacterium nucleatum PK1594 to mammalian cells and its coaggregation with periodontopathogenic bacteria are mediated by the same galactose-binding adhesin. Oral Microbiol. Immunol. 15, 371–377 (2000).
  CAS PubMed Google Scholar
• Han, Y. W. et al. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect. Immun. 72, 2272–2279 (2004). This publication provides evidence in a preclinical model to support the association of fusobacteria with adverse pregnancy outcomes in humans.
  CAS PubMed PubMed Central Google Scholar
• Xu, M. et al. FadA from Fusobacterium nucleatum utilizes both secreted and nonsecreted forms for functional oligomerization for attachment and invasion of host cells. J. Biol. Chem. 282, 25000–25009 (2007).
  CAS PubMed Google Scholar
• Fardini, Y. et al. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol. Microbiol. 82, 1468–1480 (2011).
  CAS PubMed PubMed Central Google Scholar
• Aagaard, K. et al. The placenta harbors a unique microbiome. Sci. Transl Med. 6, 237ra65 (2014).
  PubMed PubMed Central Google Scholar
• Hatakeyama, M. Helicobacter pylori CagA and gastric cancer: a paradigm for hit-and-run carcinogenesis. Cell Host Microbe 15, 306–316 (2014).
  CAS PubMed Google Scholar
• Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012).
  CAS PubMed PubMed Central Google Scholar
• Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299–306 (2012).
  CAS PubMed PubMed Central Google Scholar
• Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15, 382–392 (2014).
  CAS PubMed PubMed Central Google Scholar
• Pascal, V. et al. A microbial signature for Crohn’s disease. Gut 66, 813–822 (2017).
  CAS PubMed Google Scholar
• McCoy, A. N. et al. Fusobacterium is associated with colorectal adenomas. PLOS ONE 8, e53653 (2013).
  CAS PubMed PubMed Central Google Scholar
• Gur, C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 344–355 (2015).
  CAS PubMed PubMed Central Google Scholar
• Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443–1448 (2017).
  CAS PubMed PubMed Central Google Scholar
• Feng, Q. et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat. Commun. 6, 6528 (2015).
  CAS PubMed Google Scholar
• Yu, J. et al. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Int. J. Cancer 139, 1318–1326 (2016).
  CAS PubMed Google Scholar
• Li, Y.-Y. et al. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients. World J. Gastroenterol. 22, 3227–3233 (2016).
  CAS PubMed PubMed Central Google Scholar
• Al-Hebshi, N. N. et al. Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci. Rep. 7, 1834 (2017).
  PubMed PubMed Central Google Scholar
• Zhao, H. et al. Variations in oral microbiota associated with oral cancer. Sci. Rep. 7, 11773 (2017).
  PubMed PubMed Central Google Scholar
• Audirac-Chalifour, A. et al. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PLOS ONE 11, e0153274 (2016).
  PubMed PubMed Central Google Scholar
• Hsieh, Y.-Y. et al. Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci. Rep. 8, 158 (2018).
  PubMed PubMed Central Google Scholar
• Yamamura, K. et al. Human microbiome Fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin. Cancer Res. 22, 5574–5581 (2016).
  CAS PubMed Google Scholar
• Warren, R. L. et al. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 1, 16 (2013).
  PubMed PubMed Central Google Scholar
• Dejea, C. M. et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl Acad. Sci. USA 111, 18321–18326 (2014).
  CAS PubMed PubMed Central Google Scholar
• Guo, S. et al. A simple and novel fecal biomarker for colorectal cancer: ratio of Fusobacterium nucleatum to probiotics populations, based on their antagonistic effect. Clin. Chem. 64, 1327–1337 (2018).
  PubMed Google Scholar
• Mima, K. et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 65, 1973–1980 (2015). This molecular epidemiology study highlights the association of tumoural fusobacterial levels with worse prognosis in colorectal cancer.
  PubMed Google Scholar
• Yu, T. et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170, 548–563 (2017). This work explores the links between fusobacteria, colon cancer and autophagy, suggesting that fusobacteria may confer chemoresistance in colon cancers.
  CAS PubMed PubMed Central Google Scholar
• Tahara, T. et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74, 1311–1318 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ito, M. et al. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int. J. Cancer 137, 1258–1268 (2015).
  CAS PubMed Google Scholar
• Mima, K. et al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin. Transl Gastroenterol. 7, e200 (2016).
  CAS PubMed PubMed Central Google Scholar
• Mima, K. et al. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 1, 653–661 (2015).
  PubMed PubMed Central Google Scholar
• Mehta, R. S. et al. Association of dietary patterns with risk of colorectal cancer subtypes classified by Fusobacterium nucleatum in tumor tissue. JAMA Oncol. 3, 921–927 (2017).
  PubMed PubMed Central Google Scholar
• Liu, L. et al. Diets that promote colon inflammation associate with risk of colorectal carcinomas that contain Fusobacterium nucleatum. Clin. Gastroenterol. Hepatol. 16, 1622–1631 (2018).
  PubMed PubMed Central Google Scholar
• Komiya, Y. et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut https://doi.org/10.1136/gutjnl-2018-316661 (2018).
  Article PubMed Google Scholar
• Yang, G. Y. & Shamsuddin, A. M. Gal-GalNAc: a biomarker of colon carcinogenesis. Histol. Histopathol. 11, 801–806 (1996).
  CAS PubMed Google Scholar
• Coppenhagen-Glazer, S. et al. Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth. Infect. Immun. 83, 1104–1113 (2015).
  CAS PubMed PubMed Central Google Scholar
• Abed, J. et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 20, 215–225 (2016).
  CAS PubMed PubMed Central Google Scholar
• Carroll, G. C. & Sebor, R. J. Dental flossing and its relationship to transient bacteremia. J. Periodontol. 51, 691–692 (1980).
  CAS PubMed Google Scholar
• Lockhart, P. B. et al. Bacteremia associated with toothbrushing and dental extraction. Circulation 117, 3118–3125 (2008).
  CAS PubMed PubMed Central Google Scholar
• Su, L. K. et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668–670 (1992).
  CAS PubMed Google Scholar
• Moser, A. R., Pitot, H. C. & Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322–324 (1990).
  CAS PubMed Google Scholar
• Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207–215 (2013).
  CAS PubMed PubMed Central Google Scholar
• Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016–1022 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  CAS PubMed Google Scholar
• Nougayrède, J.-P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848–851 (2006).
  PubMed Google Scholar
• Sanders, B. E., Umana, A., Lemkul, J. A. & Slade, D. J. FusoPortal: an interactive repository of hybrid MinION-sequenced fusobacterium genomes improves gene identification and characterization. mSphere 3, 284 (2018).
  Google Scholar
• Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195–206 (2013). This publication and reference 74 are seminal papers supporting that fusobacteria potentiate colonic tumorigenesis.
  CAS PubMed PubMed Central Google Scholar
• White, B. D., Chien, A. J. & Dawson, D. W. Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology 142, 219–232 (2012).
  CAS PubMed Google Scholar
• Dougall, W. C., Kurtulus, S., Smyth, M. J. & Anderson, A. C. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy. Immunol. Rev. 276, 112–120 (2017).
  CAS PubMed Google Scholar
• Wang, H.-F. et al. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer. Sci. Rep. 6, 33440 (2016).
  CAS PubMed PubMed Central Google Scholar
• Dejea, C. M. et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359, 592–597 (2018).
  CAS PubMed PubMed Central Google Scholar
• Wu, Y. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis in mice via a Toll-like receptor 4/p21-activated kinase 1 cascade. Dig. Dis. Sci. 63, 1210–1218 (2018).
  CAS PubMed Google Scholar
• Routy, B. et al. The gut microbiota influences anticancer immunosurveillance and general health. Nat. Rev. Clin. Oncol. 15, 382–396 (2018).
  CAS PubMed Google Scholar
• Bennett, J. E., Dolin, R. & Blaser, M. J. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Disease (Elsevier Health Sciences, 2014).
• Liu, P.-F., Huang, I.-F., Shu, C.-W. & Huang, C.-M. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum. Curr. Mol. Med. 13, 1358–1367 (2013).
  CAS PubMed Google Scholar
• Guo, S.-H. et al. Immunization with alkyl hydroperoxide reductase subunit C reduces Fusobacterium nucleatum load in the intestinal tract. Sci. Rep. 7, 10566 (2017).
  PubMed PubMed Central Google Scholar
• Petrof, E. O., Claud, E. C., Gloor, G. B. & Allen-Vercoe, E. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef. Microbes 4, 53–65 (2013).
  CAS PubMed Google Scholar
• Blaser, M. J. Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology 139, 1819–1822 (2010).
  PubMed Google Scholar
• Blaser, M. J. Helicobacter pylori eradication and its implications for the future. Aliment. Pharmacol. Ther. 11 (Suppl. 1), 103–107 (1997).
  PubMed Google Scholar
• O’Keefe, S. J. D. et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun. 6, 6342 (2015).
  PubMed Google Scholar
• Duncan, S. H., Hold, G. L., Harmsen, H. J. M., Stewart, C. S. & Flint, H. J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 52, 2141–2146 (2002).
  CAS PubMed Google Scholar
• Jalava, J. & Eerola, E. Phylogenetic analysis of Fusobacterium alocis and Fusobacterium sulci based on 16S rRNA gene sequences: proposal of Filifactor alocis (Cato, Moore and Moore) comb. nov. and Eubacterium sulci (Cato, Moore and Moore) comb. nov. Int. J. Syst. Bacteriol. 49, 1375–1379 (1999).
  CAS PubMed Google Scholar
• Todd, S. M., Settlage, R. E., Lahmers, K. K. & Slade, D. J. Fusobacterium genomics using MinION and illumina sequencing enables genome completion and correction. mSphere 3, 284 (2018).
  Google Scholar
• Gupta, R. S. & Sethi, M. Phylogeny and molecular signatures for the phylum Fusobacteria and its distinct subclades. Anaerobe 28, 182–198 (2014).
  CAS PubMed Google Scholar
• Nie, S. et al. Fusobacterium nucleatum subspecies identification by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 53, 1399–1402 (2015).
  CAS PubMed PubMed Central Google Scholar
• Kook, J.-K. et al. Genome-based reclassification of Fusobacterium nucleatum subspecies at the species level. Curr. Microbiol. 74, 1137–1147 (2017).
  CAS PubMed Google Scholar
• Repass, J., Maherali, N. & Owen, K. Reproducibility project: cancer biology. Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. eL ife 5, 427 (2016).
  Google Scholar
• Repass, J. et al. Replication study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. eLife 7, e64900 (2018).
  Google Scholar
• Errington, T. M. et al. An open investigation of the reproducibility of cancer biology research. eLife 3, 5773 (2014).
  Google Scholar
• Boleij, A. et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin. Infect. Dis. 60, 208–215 (2015).
  CAS PubMed Google Scholar
• Arthur, J. C. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120–123 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kinder-Haake, S., Yoder, S. & Hunt Gerardo, S. Efficient gene transfer and targeted mutagenesis in Fusobacterium nucleatum. Plasmid 55, 27–38 (2006). This foundational paper establishes techniques for genetic manipulation of fusobacteria.
  CAS PubMed Google Scholar
• Nakagaki, H. et al. Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide. Infect. Immun. 78, 1185–1192 (2010).
  CAS PubMed Google Scholar
• Han, Y. W. et al. Identification and characterization of a novel adhesin unique to oral fusobacteria. J. Bacteriol. 187, 5330–5340 (2005).
  CAS PubMed PubMed Central Google Scholar
• Casasanta, M. A. et al. A chemical and biological toolbox for Type Vd secretion: characterization of the phospholipase A1 autotransporter FplA from Fusobacterium nucleatum. J. Biol. Chem. 292, 20240–20254 (2017).
  CAS PubMed PubMed Central Google Scholar
• Ma, L., Ding, Q., Feng, X. & Li, F. The protective effect of recombinant FomA-expressing Lactobacillus acidophilus against periodontal infection. Inflammation 36, 1160–1170 (2013).
  CAS PubMed Google Scholar
• Wu, C. et al. Forward genetic dissection of biofilm development by Fusobacterium nucleatum: novel functions of cell division proteins FtsX and EnvC. MBio 9, 101 (2018). This recent publication expands the fusobacterial genetic toolkit.
  Google Scholar
• Han, Y. W., Ikegami, A., Chung, P., Zhang, L. & Deng, C. X. Sonoporation is an efficient tool for intracellular fluorescent dextran delivery and one-step double-crossover mutant construction in Fusobacterium nucleatum. Appl. Environ. Microbiol. 73, 3677–3683 (2007).
  CAS PubMed PubMed Central Google Scholar
• Yang, Y. et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating Toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of MicroRNA-21. Gastroenterology 152, 851–866 (2017).
  CAS PubMed Google Scholar
• Kolenbrander, P. E., Andersen, R. N. & Moore, L. V. Coaggregation of Fusobacterium nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and Selenomonas sputigena with strains from 11 genera of oral bacteria. Infect. Immun. 57, 3194–3203 (1989).
  CAS PubMed PubMed Central Google Scholar
• Tomkovich, S. et al. Locoregional effects of microbiota in a preclinical model of colon carcinogenesis. Cancer Res. 77, 2620–2632 (2017).
  CAS PubMed PubMed Central Google Scholar
• Kokes, M. et al. Integrating chemical mutagenesis and whole-genome sequencing as a platform for forward and reverse genetic analysis of Chlamydia. Cell Host Microbe 17, 716–725 (2015).
  CAS PubMed PubMed Central Google Scholar
• Zarkavelis, G. et al. Current and future biomarkers in colorectal cancer. Ann. Gastroenterol. 30, 613–621 (2017).
  PubMed PubMed Central Google Scholar
• Imperiale, T. F., Ransohoff, D. F. & Itzkowitz, S. H. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 371, 187–188 (2014).
  CAS PubMed Google Scholar
• Nakatsu, G. et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat. Commun. 6, 8727 (2015).
  CAS PubMed Google Scholar
• Peng, B.-J. et al. Diagnostic performance of intestinal Fusobacterium nucleatum in colorectal cancer: a meta-analysis. Chin. Med. J. 131, 1349–1356 (2018).
  PubMed PubMed Central Google Scholar
• Huang, Q., Peng, Y. & Xie, F. Fecal fusobacterium nucleatum for detecting colorectal cancer: a systematic review and meta-analysis. Int. J. Biol. Markers https://doi.org/10.1177/1724600818781301 (2018).
  Google Scholar
• Sze, M. A. & Schloss, P. D. Leveraging existing 16S rRNA gene surveys to identify reproducible biomarkers in individuals with colorectal tumors. MBio 9, 7 (2018).
  Google Scholar
• Kaplan, A. et al. Characterization of aid1, a novel gene involved in Fusobacterium nucleatum interspecies interactions. Microb. Ecol. 68, 379–387 (2014).
  CAS PubMed PubMed Central Google Scholar
• Lima, B. P., Shi, W. & Lux, R. Identification and characterization of a novel Fusobacterium nucleatum adhesin involved in physical interaction and biofilm formation with Streptococcus gordonii. Microbiologyopen 6, e00444 (2017).
  PubMed Central Google Scholar
• Park, J., Shokeen, B., Haake, S. K. & Lux, R. Characterization of Fusobacterium nucleatum ATCC 23726 adhesins involved in strain-specific attachment to Porphyromonas gingivalis. Int. J. Oral Sci. 8, 138–144 (2016).
  PubMed Central Google Scholar
• Kinder, S. A. & Holt, S. C. Localization of the Fusobacterium nucleatum T18 adhesin activity mediating coaggregation with Porphyromonas gingivalis T22. J. Bacteriol. 175, 840–850 (1993).
  CAS PubMed PubMed Central Google Scholar
• Liu, P.-F. et al. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: implication for treatment of periodontal infection and halitosis. Vaccine 28, 3496–3505 (2010).
  CAS PubMed PubMed Central Google Scholar
• Bolstad, A. I., Jensen, H. B. & Bakken, V. Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin. Microbiol. Rev. 9, 55–71 (1996).
  CAS PubMed PubMed Central Google Scholar
• Riordan, T. Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre’s syndrome. Clin. Microbiol. Rev. 20, 622–659 (2007).
  CAS PubMed PubMed Central Google Scholar